Cyrona Cell Podcast: Stem Cell Therapy in Malaysia
Welcome to the Cyrona Cell Podcast, your trusted source for clear, doctor-led conversations about stem cell therapy and regenerative medicine in Malaysia.
Hosted by the team at Cyrona Cell in Kuala Lumpur, this podcast explores how mesenchymal stem cells (MSCs), exosome support, and evidence-informed cell-based care may help patients living with chronic inflammation, immune imbalance, and long-term degenerative conditions.
We discuss:
• How stem cell therapy works in real clinical settings
• What current research supports — and what it does not
• Eligibility and safety screening for treatment
• Conditions such as osteoarthritis, diabetes, neurological disorders, autoimmune diseases, and more
• What international patients can expect when seeking treatment in Malaysia
• Realistic outcomes, risks, and ethical standards in regenerative medicine
At Cyrona Cell, we believe in honest medicine — not hype. Every episode focuses on transparency, medical screening, patient suitability, and integrating cell therapy into a broader treatment plan.
If you are considering stem cell therapy in Kuala Lumpur and want medically grounded information before making a decision, this podcast is designed for you.
New episodes are released regularly.
Cyrona Cell Podcast: Stem Cell Therapy in Malaysia
New Umbilical Cord Exosome Study: What Early Safety Results Mean
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
In this episode, we explore a new Phase 1 clinical trial that evaluated umbilical cord-derived exosomes as a potential treatment for sudden hearing loss that did not respond to steroid therapy. Learn what researchers discovered about the treatment's safety, the early signs of effectiveness, and why experts say it's still too soon to draw conclusions.
You'll learn:
- What umbilical cord exosomes are and how they differ from traditional stem cell therapy
- Why researchers tested this treatment for patients with sudden hearing loss that didn't improve with steroids
- The key safety findings from the Phase 1 clinical trial, including the most common side effects
- What researchers observed about hearing improvement and why the results are considered preliminary
- Why the timing of treatment may play an important role in patient outcomes
- How this study fits into the growing field of cell-free regenerative medicine
- Why is more research needed before exosome therapy becomes an approved treatment option
Whether you're interested in regenerative medicine, hearing health, or the latest clinical research, this episode explains what this early study found and what it still leaves unanswered.
Blog Link: New Umbilical Cord Exosome Study: What Early Safety Results Mean